Drug Search Results
More Filters [+]

Merotocin

Alternative Names: merotocin
Latest Update: 2023-01-18
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: OXTR Agonist

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: Topical,Nasal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Ferring
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Merotocin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Obstetric Labor, Premature

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

MERMAID

P2

Terminated

Obstetric Labor, Premature

2022-11-11

24%

Recent News Events

Date

Type

Title